PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Nicotinamide→

Nicotinamide PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
98-92-0
Molecular formula
C6H6N2O
Molecular weight
122.1246 g/mol
Drug class
Vitamin B3 (niacinamide)water-soluble vitamin and NAD/NADP precursor
Mechanism of action
Serves as a precursor for nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), coenzymes required for redox metabolism, energy production, DNA repair and cellular signalling.
Indications / reported uses
  • Prevention and treatment of niacin deficiency and pellagra
  • Use in other dermatological or metabolic conditions is formulation- and evidence-specific and should not be inferred from the vitamin’s biochemical role alone

Sources: NIH Office of Dietary Supplements — Niacin fact sheet · NHS — Vitamins and minerals: vitamin B3 · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Nicotinamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Nicotinamide Permitted Daily Exposure (PDE) report (the Nicotinamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Nicotinamide Occupational Exposure Limit (OEL) report (the Nicotinamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.